Ultima Genomics Adds Tenured Strategic and Technology Leadership In Preparation for Commercial Launch
Shlomey Derhi will join the Company's R&D and engineering leadership as Head of Architecture and Integration and will be focused on accelerating technology development of the Company's unique sequencing architecture.
- Shlomey Derhi will join the Company's R&D and engineering leadership as Head of Architecture and Integration and will be focused on accelerating technology development of the Company's unique sequencing architecture.
- "We are excited to have two proven and tenured industry leaders join our leadership team at this important stage of our Company," said Gilad Almogy, CEO and founder of Ultima Genomics.
- She has deep scientific, technical and commercial expertise and will be instrumental in driving customer success, strategy and commercial focus as we transition from early access to commercial launch.
- He will be pivotal as we prepare our first product, the UG100™ for commercial launch, and continue to advance our unique sequencing architecture."